Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.
Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Opioids have a bad name these days. But let’s not forget that they were once considered a first-line treatment for depression before the discovery of MAOIs and tricyclics in the 1950s. That history has been revived recently by buprenorphine, a partial opioid agonist that was fast-tracked by the FDA for treatment-resistant depression.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.